GlassScriptPhysician profile
David Brian Dickerson
NPI 1033317219
$11,755.62
in general payments reported to CMS, 2019-2025
43 companies · $4,239 in 2025
The $4,239 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $397 · 2021: $816 · 2022: $774 · 2023: $2,697 · 2024: $2,027 · 2025: $4,239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,581 · Travel and Lodging: $3,133 · Consulting Fee: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,580.75 |
| Travel and Lodging | $3,132.92 |
| Consulting Fee | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,430.70 | 2021-2025 | Proclaim, Eterna |
| Intellijoint Surgical INC. | $2,370.69 | 2020-2025 | Intellijoint Hip |
| Si-Bone, INC. | $1,580.37 | 2023-2024 | |
| Radius Health, INC. | $823.18 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $744.79 | 2019-2025 | Persona, Mymobility Platform |
| Smith+Nephew, INC. | $542.61 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $457.19 | 2019-2025 | Salvation, Aequalis Perform Reversed, Inspace |
| Depuy Synthes Sales INC. | $442.84 | 2019-2024 | Lcp, Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $199.21 | 2023-2024 | Exparel, Iovera, Zilretta |
| Heraeus Medical, LLC. | $193.23 | 2021-2025 | |
| Horizon Therapeutics Plc | $190.08 | 2020-2022 | |
| Seapearl East, INC | $180.04 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $153.45 | 2019-2024 | Euflexxa |
| Eclipse Technology Solutions INC. | $143.20 | 2023-2025 | |
| Curonix LLC | $130.15 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $128.74 | 2024 | Maci |
| Heron Therapeutics, INC. | $125.02 | 2021-2024 | Zynrelef |
| Amgen INC. | $104.87 | 2019-2025 | Evenity, Prolia |
| Acera Surgical, INC. | $76.50 | 2024 | Restrata Wound Matrix |
| Bioventus LLC | $74.99 | 2021-2024 | Durolane |
| Vertex Pharmaceuticals Incorporated | $73.81 | 2024-2025 | |
| Pacira Therapeutics, INC. | $71.01 | 2019-2021 | |
| Medacta USA, INC. | $60.00 | 2021-2024 | |
| Tactile Systems Technology INC | $54.10 | 2020-2025 | Nimbl, Flexitouch Plus |
| Kowa Pharmaceuticals America, INC. | $45.29 | 2023 | Seglentis |
| Orthofix Medical, INC. | $30.92 | 2024 | Physio-Stim |
| Kyowa Kirin, INC. | $29.28 | 2023-2024 | Crysvita |
| Sanofi-Aventis U.S. LLC | $28.00 | 2021-2022 | |
| Globus Medical, INC. | $27.14 | 2025 | Senza |
| Tersera Therapeutics LLC | $25.00 | 2019 | |
| Linkbio Corp | $24.88 | 2025 | |
| Vertos Medical, INC. | $21.18 | 2020 | |
| Ermi LLC | $21.03 | 2021 | |
| Zimvie INC. | $18.40 | 2023 | |
| Almatica Pharma LLC | $18.23 | 2025 | Teriparatide |
| Ethicon US, LLC | $17.00 | 2019 | |
| Ebi, LLC | $15.59 | 2025 | Biomet Ebi Bone Healing System |
| Pfizer INC. | $14.93 | 2020 | |
| Zyla Life Sciences, INC. | $14.84 | 2020 | |
| Next Science LLC | $14.78 | 2021 | |
| Wright Medical Technology, INC. | $13.39 | 2019 | |
| Djo, LLC | $13.13 | 2024 | Donjoy |
| Cashflow Solutions, LLC | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.